It was initially identified as being overexpressed in prostate cancer tissues and cell lines compared to corresponding normal controls.[10] In recent years, elevated expression of lncRNA CBR3-AS1 has been observed in various cancer types, and its overexpression has been associated with prognostic significance.[11–19]. Here, CBR3 is linked to cancer.